1. Home
  2. XELB vs PYPD Comparison

XELB vs PYPD Comparison

Compare XELB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.53

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.20

Market Cap

77.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
PYPD
Founded
2011
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
77.4M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
XELB
PYPD
Price
$1.53
$4.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$3.00
$12.00
AVG Volume (30 Days)
33.4K
48.8K
Earning Date
11-19-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$2.30
52 Week High
$4.52
$5.12

Technical Indicators

Market Signals
Indicator
XELB
PYPD
Relative Strength Index (RSI) 50.58 43.87
Support Level $1.51 $4.01
Resistance Level $1.60 $4.38
Average True Range (ATR) 0.18 0.19
MACD -0.02 0.01
Stochastic Oscillator 62.01 17.60

Price Performance

Historical Comparison
XELB
PYPD

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: